El coronavirus y la crisis de la medicina
Resumen
La epidemia del Covid 19, tiene un componente mediático sin antecedentes en la historia de la medicina, esto sumado a la falta de liderazgo de gobiernos e instituciones especializadas, ha generado miles de voces con mensajes equívocos, generados a partir de experiencias personales y no de un método científico. El presente editorial es un llamado de atención ante la ineficacia mostrada en la toma de decisiones e implementación de políticas sanitarias, las que han sido tomadas al calor del momento
Descargas
Citas
2. Nussbaumer-Streit B, Mayr V, Dobrescu AIulia, Chapman A, Persad E, Klerings I, Wagner G, Siebert U, Christof C, Zachariah C,Gartlehner G. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No.: CD013574. DOI: 10.1002/14651858.CD013574
3. Mia, A., Griffiths, M. Letter to the Editor: The economic and mental health costs of COVID-19 to immigrants, Journal of Psychiatric Research 128 (2020) https://doi.org/10.1016/j.jpsychires.2020.06.003
4. British Lung Foundation. Coronavirus and COVID-19: What is social shielding and who needs to do this? 2020. Disponible en: https://www.blf.org.uk/support-for-you/coronavirus/what-is-social-shielding
5. Organización Mundial de la Salud. Recomendaciones sobre el uso de mascarillas en el contexto de la COVID-19: orientaciones provisionales, 6 de abril de 2020. Organización Mundial de la Salud. https://apps.who.int/iris/handle/10665/331789. License: CC BY-NC-SA 3.0 IGO)
6. Mingming Lianga,Liang Gaoc,Ce Cheng, Qin Zhoue,and others,Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis, Travel Medicine and Infectious Disease, May, 2020
7. (Cowling BJ, Fung RO, Cheng CK, Fang VJ, Chan KH, Seto WH, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PloS One 2008;3:e2101https://doi.org/10. 1371/journal.pone.0002101.)
8. Cowling BJ, Chan K, Fang VJ, Cheng CK, Fung RO, Wai W, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 2009;151:437–46)
9. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. doi:10.1016/j.antiviral.2020.104787
10. Chaccour C, Hammann F, Ramón-García S, Rabinovich NR. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. Am J Trop Med Hyg. 2020;102(6):1156-1157. doi:10.4269/ajtmh.20-0271
11. Gautret, P., Lagier, J.C., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V.E., Dupont, H.T. and Honoré, S., 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, p.105
12. Rosenberg ES, Dufort EM, Udo T, et al. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State [published online ahead of print, 2020 May 11]. JAMA. 2020;323(24):2493-2502. doi:10.1001/jama.2020.8630
Derechos de autor 2020 Práctica Familiar Rural
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-CompartirIgual 4.0.